|
STRN4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.82579999999222E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.77779999996653E-06 |
| Normal-vs-Stage2 |
9.135600E-02 |
| Normal-vs-Stage3 |
1.336010E-02 |
| Normal-vs-Stage4 |
7.022700E-03 |
| Stage1-vs-Stage2 |
2.052200E-01 |
| Stage1-vs-Stage3 |
7.466000E-02 |
| Stage1-vs-Stage4 |
2.760200E-01 |
| Stage2-vs-Stage3 |
9.825400E-01 |
| Stage2-vs-Stage4 |
7.496400E-01 |
| Stage3-vs-Stage4 |
6.604000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.017720E-03 |
| Normal-vs-AfricanAmerican |
1.7298999999138E-07 |
| Normal-vs-Asian |
1.524250E-02 |
| Caucasian-vs-AfricanAmerican |
1.165440E-04 |
| Caucasian-vs-Asian |
2.617800E-01 |
| AfricanAmerican-vs-Asian |
4.624800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.804200E-03 |
| Normal-vs-Female |
1.44970000004463E-07 |
| Male-vs-Female |
3.166100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.419800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.31119999999363E-05 |
| Normal-vs-Age(61-80Yrs) |
5.246200E-04 |
| Normal-vs-Age(81-100Yrs) |
5.743800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.780000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.700000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.878400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.028600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.863600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.913970E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.74870007363381E-10 |
| Normal-vs-Grade 2 |
3.68510000000599E-05 |
| Normal-vs-Grade 3 |
1.122350E-02 |
| Normal-vs-Grade 4 |
9.755600E-03 |
| Grade 1-vs-Grade 2 |
4.13350000000312E-05 |
| Grade 1-vs-Grade 3 |
3.08409999760784E-08 |
| Grade 1-vs-Grade 4 |
1.2829000000103E-06 |
| Grade 2-vs-Grade 3 |
4.330000E-02 |
| Grade 2-vs-Grade 4 |
3.360600E-01 |
| Grade 3-vs-Grade 4 |
6.201000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.373820E-04 |
| Normal-vs-ccB subtype |
4.516000E-02 |
| ccA subtype-vs-ccB subtype |
1.646430E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.842880E-03 |
| Normal-vs-N1 |
5.075000E-01 |
| N0-vs-N1 |
3.912000E-01 |
|
|
